IRIS
RONCA, ANNALISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 246
EU - Europa 178
AS - Asia 98
AF - Africa 3
OC - Oceania 1
SA - Sud America 1
Totale 527
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 238
IE - Irlanda 68
IT - Italia 49
CN - Cina 46
SG - Singapore 43
SE - Svezia 26
DE - Germania 10
CA - Canada 8
GB - Regno Unito 7
VN - Vietnam 6
HU - Ungheria 4
NL - Olanda 3
AT - Austria 2
FI - Finlandia 2
FR - Francia 2
ZA - Sudafrica 2
AR - Argentina 1
AU - Australia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
IN - India 1
LK - Sri Lanka 1
NG - Nigeria 1
NO - Norvegia 1
PL - Polonia 1
RO - Romania 1
TR - Turchia 1
Totale 527
Salva come PNG Salva come JPEG
Città #
Dublin 66
Chandler 46
Ann Arbor 37
Singapore 32
Boardman 17
Ashburn 16
Parma 14
Shanghai 12
Beijing 11
Bologna 7
Princeton 7
Dong Ket 6
Seattle 6
Bremen 5
Wilmington 5
Des Moines 4
Guangzhou 4
New York 4
Santa Clara 4
Carpi 3
Dallas 3
Dearborn 3
Los Angeles 3
Milan 3
Modena 3
Ottawa 3
Alcamo 2
Amsterdam 2
Bagnolo in Piano 2
Boston 2
Cape Town 2
Falls Church 2
Fremont 2
Helsinki 2
Redwood City 2
Toronto 2
Torrile 2
Vienna 2
Woodbridge 2
Zhengzhou 2
Ankara 1
Borås 1
Brescia 1
Brno 1
Bucharest 1
Changsha 1
Chicago 1
Colombo 1
Costa Volpino 1
Dongguan 1
Edinburgh 1
Fucecchio 1
Fushan 1
Grafing 1
Hangzhou 1
Huizen 1
Ittigen 1
Jinan 1
Kolkata 1
Kunming 1
Lagos 1
London 1
Menlo Park 1
Montreal 1
Nanjing 1
Nürnberg 1
Oslo 1
Oxford 1
Phoenix 1
Reggio Nell'emilia 1
Roncadelle 1
San Diego 1
Secaucus 1
Sydney 1
Taiyuan 1
Tenhult 1
Trieste 1
Villanuova Sul Clisi 1
Warsaw 1
Xian 1
Totale 392
Salva come PNG Salva come JPEG
Nome #
Probucol treatment is associated with an ABCA1-independent mechanism of cholesterol efflux to lipid poor apolipoproteins from foam cell macrophages 100
Lipoprotien(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a) 67
Anti-ApoA-1 IgGs in Familial Hypercholesterolemia Display Paradoxical Associations with Lipid Profile and Promote Foam Cell Formation 57
The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitors 55
Efficacy of Nutraceutical Combination of Monacolin K, Berberine, and Silymarin on Lipid Profile and PCSK9 Plasma Level in a Cohort of Hypercholesterolemic Patients 54
Effects of a dietary intervention with Mediterranean vs lacto-ovo vegetarian diets on HDL function: results from the CARDIVEG study 52
HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD) 48
Effect of a PCSK9 Inhibitor and a Statin on Cholesterol Efflux Capacity: a Limitation of Current Cholesterol-Lowering Treatments? 39
High Density Lipoprotein-Based Therapeutics: Novel Mechanism of Probucol in Foam Cells 32
Plasma HDL pattern, cholesterol efflux and cholesterol loading capacity of serum in carriers of a novel missense variant (Gly176Trp) of endothelial lipase 28
Does fish oil supplementation increase cholesterol efflux capacity in familial hypercholesterolaemia? 16
IMPAIRED HDL CHOLESTEROL EFFLUX CAPACITY IN SUBJECTS WITH METABOLICALLY-BUT NOT GENETICALLY-DRIVEN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) 5
TRANSLATING THE FINDINGS RELATED TO ANTI-APOLIPOPROTEIN A-1 IGG IN FAMILIAL HYPERCHOLESTEROLEMIA TOWARDS THE IDENTIFICATION OF A NEW ENDOGENOUS DISRUPTOR OF CELLULAR CHOLESTEROL HOMEOSTASIS 5
ANTIBODIES AGAINST APOLIPOPROTEIN A-1 AS DISRUPTORS OF CELLULAR CHOLESTEROL HOMEOSTASIS PROMOTING FOAM CELL FORMATION 4
Totale 562
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.830
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202026 0 0 0 0 1 3 4 1 6 0 0 11
2020/202164 0 2 0 4 6 7 3 6 4 18 4 10
2021/202265 7 9 3 6 1 3 3 3 6 8 1 15
2022/2023226 13 17 9 9 27 14 2 26 86 1 14 8
2023/2024103 5 12 1 5 12 16 7 9 6 9 3 18
2024/202578 3 14 18 15 28 0 0 0 0 0 0 0
Totale 562